Article Details
Retrieved on: 2024-10-07 23:14:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The trial findings support off-label use of the 40% fractional PCV13 dosing to help sustain pneumococcal vaccine immunization programs. In addition, ...
Article found on: www.contagionlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here